Alamar Biosciences Inc.
ALMR | NASDAQ
$29.16
-$1.44 (-4.71%)
Nov 2, 2026, 12:32 PM ET · Market open
TTM Period Ending | TTM 2026 Jun 30, 2026 | TTM 2025 Dec 31, 2025 | TTM 2024 Dec 31, 2024 |
|---|---|---|---|
PE Ratio | -51.11 | -48.89 | n/a |
PEG Ratio | 1.76 | n/a | n/a |
PS Ratio | 28.65 | 19.72 | n/a |
PB Ratio | 5.08 | -9.21 | n/a |
P/FCF Ratio | -44.25 | -24.39 | n/a |
P/OCF Ratio | -50.18 | -27.30 | n/a |
OCF/S Ratio | -57.10 | -72.24 | n/a |
Debt / Equity Ratio | 0.16 | -0.26 | -0.25 |
Quick Ratio | 10.23 | 2.37 | 5.56 |
Current Ratio | 11.85 | 3.99 | 6.43 |
Asset Turnover | 0.14 | 0.53 | n/a |
Interest Coverage | -57.89 | -78.14 | n/a |
Return on Equity | 7.76% | 18.76% | n/a |
Return on Assets | -8.83% | -21.30% | n/a |
Return on Invested Capital | -5.61% | -26.47% | n/a |
Dividend Yield | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a |
Gross Profit Margin | 58.01% | 56.20% | n/a |
Net Profit Margin | -62.25% | -40.18% | n/a |
Pretax Profit Margin | -61.58% | -39.29% | n/a |
Operating Profit Margin | -46.66% | -42.22% | n/a |
FCF Margin | -64.75% | -80.84% | n/a |
EBITDA Margin | -58.67% | -33.54% | n/a |
Add to Watchlist
Select watchlists to add or remove ALMR